Edit
Broken String Biosciences Ltd
https://www.brokenstringbio.com/Last activity: 12.03.2025
Active
Broken String Biosciences is a genomics company that is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation of innovative medicines, including cell and gene therapies
Location: United Kingdom, England, South Hams
Employees: 11-50
Total raised: $15M
Investors 4
| Date | Name | Website |
| 01.12.2023 | Heran Part... | heranpartn... |
| - | Dieter von... | dvhventure... |
| - | Tencent | tenx.tc |
| - | First In V... | firstinven... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.09.2023 | Series A | $15M | - |
Mentions in press and media 9
| Date | Title | Description |
| 12.03.2025 | Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline | Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium Pharmaceuticals Cambridge, UK, 12 March 2025: Shift Bio... |
| 19.09.2023 | 13th Investment for HERAN Partners: Broken String Biosciences (UK) | Cambridge, UK: Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, announced that it has closed a $15m Series A investment round, co-led ... |
| 18.09.2023 | Broken String Biosciences Closes $15M Series A Funding | Broken String Biosciences, a Cambridge, UK-based genomics company building a technology platform for cell and gene therapies, raised $15M in Series A funding. The round was led by Illumina Ventures, Mérieux Equity Partners, and HERAN Partne... |
| 18.09.2023 | Broken String Biosciences closes $15M Series A funding round | Cambridge, UK - Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Se... |
| 18.09.2023 | UK’s Broken String Biosciences raises €14M to develop, commercialise its INDUCE-seq tech: Know more | Read this article in: Cambridge-based Broken String Biosciences, a genomics company focused on creating safer cell and gene therapies, announced on Monday that it has raised $15M (approximately €14M) in a Series A round of funding. The inve... |
| 18.09.2023 | Advancing gene therapy safety: Broken String raises $15M for DNA break mapping platform | UK-based biotech firm Broken String Biosciences is building a platform that according to the company, accelerates the characterisation of novel genome editing technologies. The Next Generation Sequencing (NGS)-based DNA break mapping platfo... |
| 07.02.2023 | #21toWatch announces shortlist of next generation of Cambridge game-changers set for future success | cofinitive have announced the shortlist for #21toWatch 2023 which this year contains an eclectic mix of industries – biotech, cleantech, agritech, construction, automotive, deep learning, marine, life sciences, AI – all sharing the same mis... |
| 12.02.2021 | StartUPDATES: New developments from healthcare startups | Turing, based in Palo Alto, California, announced its second virtual remote work conference, Turing Boundaryless: #BuildfromAnywhere, slated for February 18th and featuring executives from major healthcare companies such as Abbott Laborator... |
| - | StartUPDATES: New developments from healthcare startups | Turing, based in Palo Alto, California, announced its second virtual remote work conference, Turing Boundaryless: #BuildfromAnywhere, slated for February 18th and featuring executives from major healthcare companies such as Abbott Laborator... |